Log in to save to my catalogue

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the...

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_41e6c37d4d19434583b0e8de81ad13a2

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial

About this item

Full title

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial

Publisher

England: BioMed Central Ltd

Journal title

Breast cancer research : BCR, 2020-10, Vol.22 (1), p.111-11, Article 111

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

When chemotherapy is indicated in patients with early breast cancer, regimens that contain anthracyclines and taxanes are established standard treatments. Gemcitabine has shown promising effects on the response and prognosis in patients with metastatic breast cancer. The SUCCESS-A trial (NCT02181101) examined the addition of gemcitabine to a standa...

Alternative Titles

Full title

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_41e6c37d4d19434583b0e8de81ad13a2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_41e6c37d4d19434583b0e8de81ad13a2

Other Identifiers

ISSN

1465-542X,1465-5411

E-ISSN

1465-542X

DOI

10.1186/s13058-020-01348-w

How to access this item